The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Raday Gilead | Chief Operating Officer | Sell(S) | 14.1M | $0.00 | $1K |
| Jul 10, 2026 | Raday Gilead | Chief Operating Officer | Option exercise(M) | 28.1M | — | $0 |
| Apr 6, 2026 | Raday Gilead | Chief Operating Officer | Sell(S) | 15.7M | $0.00 | $2K |
| Apr 6, 2026 | Raday Gilead | Chief Operating Officer | Option exercise(M) | 30.8M | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: RedHill Biopharma Ltd., SEC CIK 0001553846. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RDHL and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RDHL